TITLE

Should Leukotriene Antagonists Have Higher Priority for Asthma Control?

PUB. DATE
July 2011
SOURCE
OB/GYN Clinical Alert;Jul2011 Clinical Briefs in Primary, Vol. 16 Issue 7, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a research on the role of leukotriene inhibitors (LKT) in inhaled corticosteroids (ICS) for "controller" maintenance medication for persistent asthma.
ACCESSION #
64165979

 

Related Articles

  • Should Leukotriene Antagonists Have Higher Priority for Asthma Control? Kuritzky, Louis // Internal Medicine Alert;6/29/2011, Vol. 33 Issue 12, p96 

    The article reports on the inconsistent findings in comparator trials of using leukotriene inhibitors (LKT) with inhaled corticosteroids (ICS) as the preferred medication for asthma control.

  • Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review. Kankaanranta, Hannu; Lahdensuo, Aarne; Moilanen, Eeva; Barnes, Peter J. // Respiratory Research;2004, Vol. 5, p17 

    Many patients with persistent asthma can be controlled with inhaled corticosteroids (ICS). However, a considerable proportion of patients remain symptomatic, despite the use of ICS. We present systematically evidence that supports the different treatment options. A literature search was made of...

  • Pharmacotherapy -- add-on therapies.  // CMAJ: Canadian Medical Association Journal;9/13/2005 Supplement, Vol. 173, pS37 

    The article focuses on the effectiveness regarding the use inhaled corticosteriods (ICS)and leukotriene receptor antagonists (LTRA)as add-on therapy in treating children with asthma. The effectiveness ICS has been compared with long-acting bronchodilators (LABA) such as salmenterol or...

  • Seasonal patterns of Asthma medication fills among diverse populations of the United States. Turi, Kedir N.; Gebretsadik, Tebeb; Lee, Rees L.; Hartert, Tina V.; Evans, Amber M.; Stone, Cosby; Sicignano, Nicholas M.; Wu, Ann C; Iribarren, Carlos; Butler, Melissa G.; Mitchel, Edward; Morrow, James; Larkin, Emma K.; Wu, Pingsheng // Journal of Asthma;Sep2018, Vol. 55 Issue 7, p764 

    Objective: Nonadherence to controller and overuse of reliever asthma medications are associated with exacerbations. We aimed to determine patterns of seasonal asthma medication use and to identify time period(s) during which interventions to improve medication adherence could reduce asthma...

  • Antileukotriene agents in asthma: The dart that kills the elephant? Renzi, Paolo M. // CMAJ: Canadian Medical Association Journal;1/26/99, Vol. 160 Issue 2, p217 

    Reviews the development, mechanism of action, and clinical and toxic effects of the leukotriene synthesis inhibitors and receptor antagonists that are entering the North American market. Belief that the persistence of airway inflammation is the cause of mechanical changes and symptoms of...

  • Breathe easier. Gordon, Mary Ebitt // Self;Apr97, Vol. 19 Issue 4, p95 

    Reports on the availability of leukotriene receptor antagonists or inhibitors, oral medications for asthma sufferers. Drugs in the category introduced in the market; Need for doctor's prescription on the kind of drug suited for severity of asthma.

  • Pharmacogenetics of Anti-Inflammatory Therapy in Asthma: Corticosteroids and Leukotriene Antagonists. Koster, Ellen S.; Maitland-van der Zee, Anke-Hilse; Vijverberg, Susanne J. H.; van der Ent, Cornelis K.; Raaijmakers, Jan A. M. // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Sep2010, Vol. 9 Issue 3, p267 

    No abstract available.

  • Leukotriene receptor antagonists as add-on therapy for adults with asthma. Thomson, N.C.; Shepherd, M. // Thorax;Mar2003, Vol. 58 Issue 3, p190 

    Assessment of the current evidence for the use of leukotriene receptor antagonists as add-on therapy at steps 3 and 4 of the guidelines for adults with moderate to severe asthma.

  • Antileukotrienes as Adjunctive Therapy in Acute Asthma. Kuitert, Lieske M. E.; Watson, Danie // Drugs;2007, Vol. 67 Issue 12, p1665 

    The leukotriene receptor antagonists (LTRAs) are a comparatively new class of asthma drugs that exhibit both bronchodilator and anti-inflammatory properties. There is a substantial body of evidence for their benefit in the management of chronic asthma in both adults and children, and...

  • Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis. Miligkos, Michael; Bannuru, Raveendhara R.; Alkofide, Hadeel; Kher, Sucharita R.; Schmid, Christopher H.; Balk, Ethan M. // Annals of Internal Medicine;11/17/2015, Vol. 163 Issue 10, p756 

    Background: Leukotriene-receptor antagonists (LTRAs) are recommended as an alternative treatment in patients with mild asthma, but their effect compared with placebo is unclear.Purpose: To determine the benefits and harms of LTRAs as monotherapy or in combination with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics